Revolutionary gene therapy gives vision to children born blind

Children with severe childhood blindness get ‘life-changing improvements’ after gene therapy
Children with severe childhood blindness get ‘life-changing improvements’ after gene therapy

New genetic therapy has brought “life-changing improvements” in the vision of the infants born with one of the most severe forms of childhood blindness.

According to Kings College London, an experimental trial of genetic therapy done by the Moorfields Eye Hospital, London, and UCL Institute of Ophthalmology has helped four toddlers born blind to gain revolutionary changes in their sight.

Also Read: Discover 8 foods to keep your eyesight sharp

Before the therapy, the children who were legally registered blind were capable of only distinguishing between dark and light, but after the treatment, all of the children involved in the experiment noted improvements, while some of the young children started writing and drawing.

The experiment was supported by MeiraGTx, and researchers from the King’s Centre for Gene Therapy and Regenerative Medicine were involved in the breakthrough study.

Professor James Bainbridge, a consultant retinal surgeon at Moorfields Eye Hospital, said, “Sight impairment in young children has a devastating effect on their development. Treatment in infancy with this new genetic medicine can transform the lives of those most severely affected."

Professor Michel Michaelides added, “We have, for the first time, an effective treatment for the most severe form of childhood blindness and a potential paradigm shift to treatment at the earliest stages of the disease. The outcomes for these children are hugely impressive and show the power of gene therapy to change lives.”

The research published in The Lancet found that the gene therapy at an early age could bring dramatic improvement in the vision of the children with rare genetic deficiency that affects the 'AIPL1' gene.

Notably, it was not the first time when gene therapy has provided successful gene therapy for genetic blindness (RPE65 deficiency) has been available on the NHS since 2020.

Researchers believe that the new findings would give hope to the children who unfortunately are affected by both rare and more common forms of genetic blindness.

Also Read: Blind woman regains vision after groundbreaking AI surgery

Related
Read more : Health

US cuts to HIV aid may lead to 4 million deaths by 2029, UN warns

US cuts to HIV aid may lead to 4 million deaths by 2029, UN warns
Experts cautioned that the US is 'abandoning the fight' just as ending AIDS is within reach

Ritz Peanut Butter Crackers recalled nationwide over labeling error

Ritz Peanut Butter Crackers recalled nationwide over labeling error
Check out the list of the recalled Ritz cracker sandwich cartons

About 1 in 3 US Teens are prediabetic, CDC data suggests

About 1 in 3 US Teens are prediabetic, CDC data suggests
Experts warn of a significant spike in early-onset Type 2 diabetes that the healthcare system may not be prepared for

Lead exposure may significantly affect kids' memory, study

Lead exposure may significantly affect kids' memory, study
Lead exposure in women or during early childhood is likely to increase kids' risk of cognitive decline

'Old' brains significantly increase mortality risk, Alzheimer's, study

'Old' brains significantly increase mortality risk, Alzheimer's, study
Results indicated that 6–7% of individuals had “extremely youthful” or “extremely aged” brains

Researchers find how processed meat increases risk of chronic diseases

Researchers find how processed meat increases risk of chronic diseases
Results indicated that people who had one hot dog a day had an 11% increased risk of type 2 diabetes

Air pollution associated with common brain tumors, study

Air pollution associated with common brain tumors, study
Meningiomas are tumours that develop in the layers of tissue covering the brain and spinal cord

Malaria treatment breakthrough: First-ever treatment approved for newborns

Malaria treatment breakthrough: First-ever treatment approved for newborns
Malaria treatment gap closed after first drug approved for newborns and infants under 11 pounds